- severe respiratory symptoms related to covid-19 requiring oxygen or intensive care (high flow oxygen or mechanical ventilation or ecmo) - patients with preexisting pulmonary diseases requiring oxygen supply - patients with history of hypersensitivity to camostat or niclosamide or to any ingredients to any of the two drugs - patients with heart failure (nyha iii or nyha iv) - patients with proven malignant tumor - patients diagnosed with influenza infection - pregnancy or breastfeeding - immunocompromised patients - creatinine clearance < 60 ml/min - aspartate aminotransferase (ast) / alanine aminotransferase (alt) > 2 times upper limit of normal (uln)

- severe respiratory symptoms related to covid-19 requiring oxygen or intensive care (high flow oxygen or mechanical ventilation or ecmo) - patients with preexisting pulmonary diseases requiring oxygen supply - patients with history of hypersensitivity to camostat or niclosamide or to any ingredients to any of the two drugs - patients with heart failure (nyha iii or nyha iv) - patients with proven malignant tumor - patients diagnosed with influenza infection - pregnancy or breastfeeding - immunocompromised patients - creatinine clearance < 60 ml/min - aspartate aminotransferase (ast) / alanine aminotransferase (alt) > 2 times upper limit of normal (uln)

- severe respiratory symptoms related to covid-19 requiring oxygene or intensive care (high flow oxygen or mechanical ventilation or ecmo) - patients with preexisting pulmonary diseases requiring oxygen supply - patients with history of hypersensitivity to camostat or niclosamide or to any ingredients to any of the two drugs - patients with heart failure (nyha iii or nyha iv) - patients with proven malignant tumor - patients diagnosed with influenza infection - pregnancy or breastfeeding - immunocompromised patients - creatinine clearance < 60 ml/min - ast/alt >2xuln

- severe respiratory symptoms related to covid-19 requiring oxygene or intensive care (high flow oxygen or mechanical ventilation or ecmo) - patients with preexisting pulmonary diseases requiring oxygen supply - patients with history of hypersensitivity to camostat or niclosamide or to any ingredients to any of the two drugs - patients with heart failure (nyha iii or nyha iv) - patients with proven malignant tumor - patients diagnosed with influenza infection - pregnancy or breastfeeding - immunocompromised patients - creatinine clearance < 60 ml/min - ast/alt >2xuln